1 / 12

EYECRYL PHAKIC TORIC

EYECRYL PHAKIC TORIC lenses are intended to be placed in the posterior chamber directly behind the iris and in front of the anterior capsule of the human crystalline lens. The lens is designed to reduce low to high myopia and co-existing astigmatism indicated in Phakic adults.

biotechhealthcare
Télécharger la présentation

EYECRYL PHAKIC TORIC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MKT1290_REV07_06-07-2020

  2. 1 Clinical Results (n=36) Vault Uncorrected Visual Acuity The results show good improvement in the uncorrected visual acuity after implantation of EYECRYL PHAKIC Range of IOLs. 1500 2 Vault height (µm) 1.5 1000 UCVA (LogMAR) Study report shows stable vault during the follow up and at the end of 4 years. 1 500 The graph also shows the stability of the uncorrected visual acuity over the period of time. All patients are found with uncorrected visual acuity within 0.275 Log MAR value at post 4 years follow up. 0.5 0 Post-op 01- Month Post-op 03- Month Post-op 06- Month Post-op 01- Year Post-op 02- Years Post-op 03- Years Post-op 04- Years 0 Post-op 01-Month Post-op 03-Month Post-op 06-Month Post-op 01-Year Post-op 02-Year Post-op 03-Year Post-op 04-Year Base Line Mean Vault (µm) 574 573 561 524 512 527 499 UCVA 1.846 0.239 0.228 0.192 0.219 0.244 0.273 0.274 Spherical Refraction -14.0 -12.0 Corrected Visual Acuity 2 Mean spherical refraction after 4 years of implantation shows excellent predictability and stability of the IOL in the eye along with the efficacy to treat wide range of Myopia. -10.0 Mean Spherical -8.0 The results show clear improvement in the corrected visual acuity after implantation of EYECRYL PHAKIC range of IOLs. Refraction (D) 1.5 -6.0 BCVA (LogMAR) -4.0 1 -2.0 The corrected visual acuity is improved with time period of 4 years in the study. All patients are found within -0.25 D at post 4 years examination. 0.0 0.5 2.0 4.0 All patients are found with corrected visual acuity within 0.098 Log MAR value at post of 4 years examination. 0 Post-op 01-Month Post-op 03-Month Post-op 06-Month Post-op 01-Year Post-op 02-Year Post-op 03-Year Post-op 04-Year Pre-op Post-op 01-Month Post-op 03-Month Post-op 06-Month Post-op 01-Year Post-op 02-Year Post-op 03-Year Post-op 04-Year Base Line Spherical Refraction (D) -12.49 -0.04 -0.06 0.00 -0.07 -0.15 -0.17 -0.24 BCVA 0.286 0.158 0.14 0.113 0.132 0.129 0.135 0.098 Endothelial cell count 4000 20 The graph shows the stable Endothelial cell count for 4 years of clinical study. 16.9 Mean Endothelial cell count IOP Post - operative IOP remains stable and within permissible limits, without IP. 15.2 14.4 3000 15 mmHg The Results show the implantation of the EYECRYL PHAKIC range of IOLs doesn’t have remarkable impact on endothelial cell loss over the period of time. 10 2000 0 Pre-op. Post-op. 1 Month Post-op. 1 Year 1000 Post-op 01-Month Post-op 03-Month Post-op 06-Month Post-op 01-Year Post-op 02-Year Post-op 03-Year Post-op 04-Year Base Line Cell Count (cell/mm2) 2630.6 2742.8 2678.2 2622.3 2612.9 2597.3 2815.9 2568.2

  3. 1 Clinical Results (n=36)

  4. Reference: 1. Dr. Alper Agca, Dr.; “Clinical Study Report- “THE RETROSPECTIVE STUDY TO EVALUATE THE LONG TERM EFFICACY, SAFETY AND REFRACTIVE OUTCOME OF PATIENT SUFFERING FROM MYOPIA AND IMPLANTED WITH PHAKIC IOL”-2020.

More Related